期刊
DRUG DISCOVERY TODAY
卷 25, 期 11, 页码 2012-2022出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2020.09.010
关键词
-
资金
- National Natural Science Foundation of China [U1903126, 81773888, 81872901]
- Guangdong Basic and Applied Basic Research Foundation [2020A1515010005, 2020A1515010605]
Quinoline (QN) derivatives are often used for the prophylaxis and treatment of malaria. Chloroquine (CQ), a protonated, weakly basic drug, exerts its antimalarial effect mainly by increasing pH and accumulating in the food vacuole of the parasites. Repurposing CQ is an emerging strategy for new indications. Given the inhibition of autophagy and its immunomodulatory action, CQ shows positive efficacy against cancer and viral diseases, including Coronavirus 2019 (COVID-19). Here, we review the underlying mechanisms behind the antimalarial, anticancer and antiviral effects of CQ. We also discuss the clinical evidence for the use of CQ and hydroxychloroquine (HCQ) against COVID-19.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据